Deutsche Bank lowered the firm’s price target on Labcorp to $240 from $265 and keeps a Hold rating on the shares post the Q1 results. The analyst says drug development headwinds offset the "solid" base business.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on LH:
- Labcorp price target lowered to $235 from $260 at Citi
- Labcorp raises FY23 adjusted EPS view $16.25-$17.75 from $16.00-$18.00
- Labcorp reports Q1 adjusted EPS $3.82, consensus $3.96
- Labcorp Announces 2023 First Quarter Results
- LABCORP DECLARES QUARTERLY DIVIDEND
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue